No single blood test directly measures insulin resistance in a standard clinical setting. Instead, doctors use a combination of fasting blood draws and calculated formulas to estimate how well your body responds to insulin. The most widely used approach combines a fasting insulin level with a fasting glucose level to produce a score called HOMA-IR, but several other options exist depending on what your doctor is looking for and how early you want to catch the problem.
Fasting Insulin: The Earliest Signal
A simple fasting insulin test is one of the most informative starting points. Your body compensates for insulin resistance by producing more insulin, so rising insulin levels can appear years before blood sugar ever climbs out of the normal range. In a study of otherwise healthy workers with only mild overweight, fasting insulin captured an earlier stage of metabolic trouble than either fasting glucose or HbA1c. When researchers compared how well each marker could identify insulin resistance, fasting insulin had an area under the curve of 0.995, essentially near-perfect discrimination, while HbA1c scored just 0.647.
This matters because standard blood work often checks only glucose or HbA1c. Those tests tell you about blood sugar control, not about how hard your pancreas is working to maintain it. By the time glucose or HbA1c rises, insulin resistance may have been building for years. Fasting insulin levels above roughly 12 to 13 µU/mL are commonly used as a cutoff for insulin resistance in people with normal blood sugar. Levels above about 10.5 µU/mL have been linked to increased risk of metabolic syndrome.
HOMA-IR: The Standard Calculation
HOMA-IR stands for Homeostatic Model Assessment of Insulin Resistance. It uses two numbers from a single fasting blood draw, your glucose and your insulin, and plugs them into a formula: multiply fasting glucose (in mmol/L) by fasting insulin (in µU/mL), then divide by 22.5. If your lab reports glucose in mg/dL, that value gets converted first. A HOMA-IR below 2.5 is generally considered normal. The World Health Organization has defined insulin resistance as a HOMA-IR above the 75th percentile of a healthy reference population, which in many studies lands around 2.5 to 3.0.
HOMA-IR is popular because it’s cheap, requires only one fasting blood sample, and correlates reasonably well with more sophisticated research methods. Its main limitation is that it reflects what’s happening in the liver more than in your muscles, so it doesn’t capture the full picture of how your body handles glucose.
QUICKI: A Mathematical Variation
The Quantitative Insulin Sensitivity Check Index uses the same two blood values as HOMA-IR but runs them through a logarithmic formula: 1 divided by (the log of your fasting insulin plus the log of your fasting glucose). Higher QUICKI values mean better insulin sensitivity, the opposite direction from HOMA-IR. Reported averages are about 0.382 for non-obese individuals, 0.331 for people with obesity, and 0.304 for those with diabetes. Some researchers consider QUICKI to have slightly better predictive power than HOMA-IR, though both tests use the same blood draw and are often reported together.
The Triglyceride-to-HDL Ratio
You may not need a specialized insulin test at all to get a rough estimate. A standard lipid panel, which most adults have had at some point, includes triglycerides and HDL cholesterol. Dividing your triglyceride number by your HDL cholesterol gives a ratio that tracks with insulin resistance. A ratio of 3.0 or higher is closely correlated with insulin resistance, and research in both adults and children shows that people in the highest range of this ratio have about 2.5 times the odds of being insulin resistant compared to those in the lowest range.
This isn’t precise enough to replace a direct insulin measurement, but it’s useful as a screening signal, particularly if you already have lipid results on hand and want to know whether further testing is worth pursuing.
The Oral Glucose Tolerance Test
A glucose tolerance test goes beyond fasting values by measuring how your body responds to a sugar load in real time. You fast overnight, drink a standardized glucose solution (usually 75 grams), and then have blood drawn at intervals, typically at one and two hours. When insulin levels are measured alongside glucose at each time point, the test reveals how aggressively your pancreas has to work to clear sugar from your blood. Insulin measured at the two-hour mark has shown excellent accuracy for detecting insulin resistance, with an area under the curve of 0.958 in one study of children with obesity.
The glucose tolerance test also allows calculation of the Matsuda Index, which estimates whole-body insulin sensitivity using glucose and insulin values from multiple time points. This gives a fuller picture than fasting-only tests because it captures both liver and muscle insulin sensitivity. The downside is that it takes two to three hours in a clinic, requires multiple blood draws, and isn’t routinely ordered unless there’s a specific reason.
The LP-IR Score: A Lipoprotein-Based Approach
A newer option uses advanced lipoprotein testing to score insulin resistance based on the size and concentration of cholesterol particles in your blood. The Lipoprotein Insulin Resistance Index (LP-IR) combines six measurements from a specialized test called NMR spectroscopy: the size and number of large VLDL particles (a type of “bad” cholesterol carrier), the size and number of small LDL particles, and the size and number of large HDL particles. People with insulin resistance tend to have larger, more numerous VLDL particles and smaller LDL and HDL particles.
The LP-IR score correlated more strongly with both HOMA-IR and the gold-standard clamp test than the triglyceride-to-HDL ratio did, and it identified insulin resistance regardless of body weight. Because it piggybacks on a test already used for cardiovascular risk assessment, it can sometimes be added at little extra cost. It’s not yet as widely available as standard blood work, but it’s increasingly offered through specialty and preventive health panels.
The Gold Standard (and Why You Won’t Get It)
The hyperinsulinemic-euglycemic clamp, developed in 1979, is considered the gold standard for measuring insulin resistance. During this procedure, a researcher infuses insulin into your bloodstream at a constant rate while simultaneously dripping in glucose to keep your blood sugar level stable. The amount of glucose needed to maintain that steady state tells researchers exactly how sensitive your tissues are to insulin. If you need a lot of glucose, your cells are responding well. If you need very little, they’re resistant.
This test is time-consuming, labor-intensive, and expensive, so it’s used almost exclusively in research settings. You won’t encounter it in a doctor’s office, but it’s the benchmark against which every other insulin resistance test is validated.
How to Prepare for Testing
Any test involving fasting insulin or fasting glucose requires an overnight fast, typically 8 to 12 hours with only water allowed. Exercise, stress, poor sleep, and caffeine can all temporarily affect insulin and glucose levels, so aim for a calm, rested morning. If you’re having a glucose tolerance test, plan to be at the lab for two to three hours and bring something to read, because you’ll be sitting and waiting between blood draws.
When requesting testing, be specific. A standard metabolic panel checks glucose but not insulin. If you want HOMA-IR calculated, you need to ask for both a fasting glucose and a fasting insulin level. Some labs calculate the score automatically when both are ordered together; others report the raw values and leave the math to your doctor.